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Background
Human Immunodeficiency Virus (HIV) is a fairly prevalent 
disease in the United States, with an estimated 1 million 
persons infected with HIV-1.1 Despite a decrease in Acquired 
Immunodeficiency Syndrome (AIDS), the prevalence of HIV 
is increasing, which has led to recent changes in HIV testing 
guidelines.2 Newly diagnosed patients should ideally be linked 
to care and receive intervention and antiretroviral therapy 
(ART) allowing them to maintain a near normal life expectancy. 
Case Presentation
The patient is a 23-year-old African American male with no 
significant past medical history. He presented to the emergency 
department (ED) with fevers, weakness, worsening right-sided 
chest pain, and shortness of breath associated with a productive 
cough. When he presented with similar symptoms two 
weeks ago, he was treated for pneumonia with azithromycin. 
Symptoms initially improved but then worsened five days 
prior to returning to the ED. He had odynophagia for the last 
three weeks causing him to avoid solid foods. Additionally, he 
reported loss of vision in his right eye for two months which 
started as blurriness but progressed to only appreciating light 
versus dark. Left eye vision was intact. 
He took no chronic medications and denied drug allergies. 
Surgical and family history was non-contributory. He 
rarely drank alcohol and denied tobacco or drug use. He is 
homosexual and became sexually active at the age of fourteen 
with inconsistent condom use. He reported a negative rapid 
HIV test at a local clinic one month ago and his last sexual 
contact was three months prior to presentation. 
Investigations
On physical exam, the patient’s vitals were temperature of 
97.6°F, heart rate 101 bpm, blood pressure 133/76 mmHg, 
respiratory rate 18 bpm, pulse oximetry 98% on room air. Head 
and neck exam revealed oral thrush and a nonreactive right 
pupil. Confrontation of visual fields revealed lack of vision 
in all four quadrants of the right eye. Eyes were anicteric and 
without conjunctival injection. Cardiovascular exam revealed 
mild tachycardia but was otherwise normal. Lungs were clear 
to auscultation. Abdomen exam was unremarkable. He had no 
lymphadenopathy and the rest of his physical exam was normal.
Lab work was significant for a hemoglobin of 11.6 g/dL, 
mean corpuscular volume of 78 fL, RDW 15.5%, and lactate 
dehydrogenase of 581 IU/L. Comprehensive metabolic panel 
was within normal limits. Chest X-ray revealed patchy bilateral 
perihilar interstitial infiltrates, more progressed compared to 
two weeks prior. A rapid HIV test in the ED was positive. CT 
of the chest showed bilateral patchy, confluent areas of ground 
glass opacity with perihilar predominance involving all lobes 
relatively sparing the bases.
Differential Diagnoses
Given his newly diagnosed HIV infection, differential 
diagnosis included community acquired pneumonia (CAP), 
Pneumocystis jirovecii pneumonia (PCP), opportunistic viral 
pneumonia, fungal pneumonia, Mycobacterium infection. His 
odynophagia was thought to be secondary to esophagitis, likely 
from Candida albicans, Cytomegalovirus (CMV), or Herpes 
Simplex Virus (HSV). Possible causes of vision loss included 
CMV retinitis, toxoplasma retinochoroiditis, and Varicella 
Zoster Virus Retinitis. 
Treatment
Infectious Disease (ID) was consulted, and he was started on 
empiric moxifloxacin to cover for CAP, including atypical 
pathogens. He was also started on IV pentamidine for possible 
PCP. Pentamidine was used secondary to a hospital shortage of 
IV trimethoprim-sulfamethoxazole (TMP-SMX). Additionally, 
he was received IV ganciclovir to empirically treat CMV 
retinitis and possible CMV or HSV esophagitis. He was started 
on fluconazole to treat thrush and possible candida esophagitis.
His rapid HIV antigen/antibody combination test was positive 
and confirmed by Western Blot. His CD4 count was 41 cells/
mcL, establishing a diagnosis of AIDS. The genotype revealed 
wild type HIV-1 with a viral load of 3.68 million copies/mL.
Upon admission, Ophthalmology performed a dilated eye exam, 
which revealed total retinal necrosis of the right eye. There was 
necrosis and fibrosis of the macula, peripheral retinal necrosis, 
as well as “frosted branch” retinitis and hemorrhage with 
“brush fire” appearance. These exam findings combined with 
a CD4 count less than 50 cells/mcL were consistent with CMV 
retinitis, and visual prognosis was poor given diffuse necrosis 
that progressed for two months. Exam of the left eye revealed 
mild cotton wool spots which could represent either early CMV 
retinitis versus HIV retinopathy. For induction treatment, he 
was continued on IV ganciclovir (eventually changed to oral 
valganciclovir).
His respiratory symptoms slowly began to improve with 
antibiotics. Bronchoscopy revealed minimal non-purulent 
secretions. Cultures from bronchoalveolar lavage (BAL) were 
negative for acid fast bacilli, respiratory viruses (including 
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8influenza A, B), and bacteria. Fungal culture showed light 
growth of Candida albicans, and cytology with silver stain was 
positive for PCP. Treatment was narrowed to IV pentamidine 
until he was able to tolerate oral treatment doses of TMP-SMX.
He was maintained on fluconazole for thrush. For his esophagitis, 
endoscopy was deferred as he was already on fluconazole for 
Candida infection as well as IV ganciclovir for treatment CMV 
retinitis, which would also treat concomitant CMV or HSV 
esophagitis.
Outcome And Follow-Up
His symptoms began to improve significantly. After his 
esophagitis resolved, he was transitioned to oral medications to 
complete treatment of his multiple opportunistic infections. He 
was discharged from the hospital to finish treatment at home and 
follow up with his ID physician later that week to initiate ART.
Discussion
This case illustrates that despite improved testing techniques, 
it is still possible for patients to present with new diagnoses of 
HIV in late stages. Moreover, false negative screening tests are 
still possible, and patients can present with new HIV/AIDS via 
multiple simultaneous opportunistic infections. Additionally, it 
reinforces treatment of various opportunistic infections.
This patient presented with a CD4 count of 41 cells/mcL but 
had a negative HIV test one month prior. This represents either 
seronegative chronic HIV infection or chronic infection with a 
false negative enzyme immunoassay (EIA) and failure to detect 
the antibody. Alternatively, it may be an atypical instance of 
acute infection prior to seroconversion with the CD4 count 
falling dramatically low before recovering to the typical 600-700 
cells/mcL.3 The latter scenario of an acute infection would place 
the primary HIV infection at roughly 6 weeks prior to admission, 
which is less likely since visual symptoms began at least 8 weeks 
prior to admission.3,4 A final possibility is fulminant HIV. Given 
his long standing risk factors and several months of visual 
symptoms (which occur at advanced immunosuppression), he 
likely had chronic HIV that was not detected. 
The CDC recommends use of rapid HIV tests so more patients 
obtain their results.4 Many outpatient facilities use the third 
generation EIA, capable of detecting HIV antibodies as early as 
three weeks after infection.5,6 All commercially used tests have 
excellent sensitivities (>99%) for detection of HIV antibodies, 
and many can detect them even before the traditional Western 
blot confirmation test can, yielding pseudo-false positive results 
that require repeat testing.5 Although these screening tests 
have excellent performance, their sensitivities are not 100%. 
There are several reported incidences of false negative EIA 
tests secondary to immune dysfunction and impaired humoral 
response, delay to seroconversion following initiation of ART, 
as well as fulminant HIV infection.7-11 
This case demonstrates the need for better access to care and 
earlier intervention. Unfortunately, this young man’s retinal 
necrosis was so advanced that he will likely never recover vision 
in his right eye. Had his HIV been diagnosed earlier, his multiple 
infections and vision loss may have been prevented. Due to an 
increasing prevalence of HIV, the 2006 revised CDC guidelines 
for HIV testing recommend screening for patients in all settings 
in an opt-out fashion, at least annual testing for those at higher 
risk, and screening to become overall more routine and not 
require separate consent.4 A new US Preventative Services Task 
Force (USPSTF) draft recommends screening all adults age 15 
to 65, with more frequent testing in high risk individuals.12
PCP usually occurs in HIV patients with CD4 counts less than 200 
cells/mcL. Patients typically develop fever, progressive dyspnea, 
nonproductive cough, chest discomfort, and uncommonly 
blebs, cysts, and pneumothorax. Severe cases are characterized 
by hypoxemia. Imaging usually demonstrates diffuse, bilateral, 
interstitial infiltrates. Diagnosis requires induced sputum 
or BAL histopathologic confirmation. Treatment of choice 
is TMP-SMX orally or parenterally in severe cases and when 
patients cannot tolerate oral medications. In cases of drug 
intolerance, IV pentamidine is the preferred treatment. Patients 
with moderate-severe disease, PaO2 less than 70 mmHg or A-a 
gradient > 35 mmHg should receive corticosteroids. Treatment 
should last 21 days, then TMP-SMX should be decreased to 
prophylactic dosing. Additionally, ART should be initiated 
within two weeks if not already started.13
CMV disease is usually in patients with HIV and CD4 counts 
less than 50 cells/mcL. CMV retinitis is a necrotizing retinitis 
that often begins unilaterally, but without treatment, viremic 
dissemination causes bilateral retinitis. Symptoms include 
scotoma, floaters, and visual field defects. Visual acuity 
decreases with central retinal lesions. Diagnosis is made by an 
ophthalmologist during a dilated eye exam with recognition of 
characteristic fluffy yellow-white retinal lesions and possible 
intra-retinal hemorrhage. Treatment for mild disease is typically 
oral valganciclovir. Moderate-severe disease is treated with 
intraocular implant of ganciclovir plus oral valganciclovir or 
iv ganciclovir alone. Induction phase is 14-21 days followed 
by maintenance with lower dose valganciclovir and regular 
ophthalmologic exams to detect relapse or immune recovery 
uveitis. Maintenance can be discontinued after six months of 
sustained quiescent retinitis and CD4 counts over 100 cells/
mcL.13
Esophagitis is characterized by odynophagia and retrosternal 
pain. In HIV patients, it is reasonable to empirically treat 
for candida, especially with the presence of oral thrush, and 
perform endoscopy if symptoms do not improve after 3-5 
days. Treatment of choice for candida esophagitis is systemic 
treatment for 14-21 days with fluconazole. CMV esophagitis 
is diagnosed by endoscopy and biopsy and is treated with IV 
ganciclovir or oral valganciclovir if tolerated for 21 days or until 
symptoms resolve. HSV esophagitis is treated with IV acyclovir 
(orally if tolerated) for 14-21 days.13
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Key Points
In accordance with revised guidelines, HIV testing should be 
routine, particularly in patients who are high risk. Clinical 
judgment should increase index of suspicion for further HIV 
testing such as nucleic acid amplification, as there are rare cases 
of seronegative AIDS as wells as false negatives despite excellent 
sensitivities.
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